(Q72092912)
Statements
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group (English)
U Thadani
M Ezekowitz
L Fenney
scientific article published on 01 August 1994